Redmile Group’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.4M Hold
1,459,599
1.95% 11
2025
Q4
$30.1M Buy
1,459,599
+160,577
+12% +$4M 2.21% 11
2025
Q3
$22.5M Buy
1,299,022
+22,346
+2% +$449K 2.19% 14
2025
Q2
$19.1M Sell
1,276,676
-31,387
-2% -$493K 2.03% 15
2025
Q1
$15.3M Sell
1,308,063
-11,700
-0.9% -$203K 1.45% 19
2024
Q4
$30.2M Buy
1,319,763
+355,416
+37% +$13.2M 2.1% 18
2024
Q3
$40.5M Sell
964,347
-49,316
-5% -$1.91M 2.38% 17
2024
Q2
$36.9M Buy
1,013,663
+78,411
+8% +$2.77M 2.23% 19
2024
Q1
$47.6M Sell
935,252
-11,645
-1% -$389K 1.75% 19
2023
Q4
$18.4M Buy
946,897
+801,286
+550% +$11.5M 0.66% 40
2023
Q3
$2.3M Hold
145,611
0.11% 58
2023
Q2
$2.42M Buy
145,611
+53,231
+58% +$873K 0.09% 66
2023
Q1
$1.29M Sell
92,380
-148
-0.2% -$1.74K 0.06% 70
2022
Q4
$942K Sell
92,528
-79,319
-46% -$819K 0.04% 66
2022
Q3
$2.2M Hold
171,847
0.09% 63
2022
Q2
$3.54M Sell
171,847
-1,425
-0.8% -$34.8K 0.14% 62
2022
Q1
$6.51M Sell
173,272
-1,270
-0.7% -$74.1K 0.2% 57
2021
Q4
$16.8M Sell
174,542
-820
-0.5% -$99.9K 0.38% 48
2021
Q3
$25.4M Sell
175,362
-20,600
-11% -$3.15M 0.44% 49
2021
Q2
$36.2M Sell
195,962
-9,916
-5% -$2.19M 0.54% 49
2021
Q1
$50.7M Sell
205,878
-715
-0.3% -$183K 0.71% 42
2020
Q4
$58.3M Sell
206,593
-2,041
-1% -$499K 0.71% 43
2020
Q3
$50.1M Buy
208,634
+6,573
+3% +$1.59M 0.92% 38
2020
Q2
$67.1M Hold
202,061
1.24% 24
2020
Q1
$46M Buy
202,061
+106,019
+110% +$21.8M 1.29% 27
2019
Q4
$23.7M Buy
+96,042
New +$9.57M 0.57% 46
2015
Q4
Sell
-25,715
Closed -$7.24M 63
2015
Q3
$7.24M Buy
+25,715
New +$5.92M 0.55% 37

Other funds holding NGNE